Task: Answer the multiple-choice question.
Query: Which compound exhibits a 15.599% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: O=c1c2ccccc2c2ccccc2c(=O)n1Cc1ccco1
b: CCCn1c(N)c(C(=O)CSc2nc(C)nc3sc(C)c(C)c23)c(=O)[nH]c1=O
Answer: b. CCCn1c(N)c(C(=O)CSc2nc(C)nc3sc(C)c(C)c23)c(=O)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(N)c(C(=O)CSc2nc(C)nc3sc(C)c(C)c23)c(=O)[nH]c1=O
CCCn1c(N)c(C(=O)CSc2nc(C)nc3sc(C)c(C)c23)c(=O)[nH]c1=O
6-amino-1-propyl-5-[2-(2,5,6-trimethylthieno[2,3-d]pyrimidin-4-yl)sulfanylacetyl]pyrimidine-2,4-dione